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Abstract
Background: Cerenkov luminescence tomography (CLT) provides the three-dimensional (3D) radiopharmaceutical
biodistribution in small living animals, which is vital to biomedical imaging. However, existing single-spectral and
multispectral methods are not very efficient and effective at reconstructing the distribution of the radionuclide tracer. In this
paper, we present a semi-quantitative Cerenkov radiation spectral characteristic-based source reconstruction method
named the hybrid spectral CLT, to efficiently reconstruct the radionuclide tracer with both encouraging reconstruction
results and less acquisition and image reconstruction time.
Methodology/Principal Findings: We constructed the implantation mouse model implanted with a 400 mCi Na
131I
radioactive source and the physiological mouse model received an intravenous tail injection of 400 mCi radiopharmaceutical
Iodine-131 (I-131) to validate the performance of the hybrid spectral CLT and compared the reconstruction results,
acquisition, and image reconstruction time with that of single-spectral and multispectral CLT. Furthermore, we performed
3D noninvasive monitoring of I-131 uptake in the thyroid and quantified I-131 uptake in vivo using hybrid spectral CLT.
Results showed that the reconstruction based on the hybrid spectral CLT was more accurate in localization and
quantification than using single-spectral CLT, and was more efficient in the in vivo experiment compared with multispectral
CLT. Additionally, 3D visualization of longitudinal observations suggested that the reconstructed energy of I-131 uptake in
the thyroid increased with acquisition time and there was a robust correlation between the reconstructed energy versus the
gamma ray counts of I-131 (r2~0:8240). The ex vivo biodistribution experiment further confirmed the I-131 uptake in the
thyroid for hybrid spectral CLT.
Conclusions/Significance: Results indicated that hybrid spectral CLT could be potentially used for thyroid imaging to
evaluate its function and monitor its treatment for thyroid cancer.
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Introduction
Cerenkov radiation was first observed as early as 1934, which
was named after Russian scientist Pavel Alekseyevich Cherenkov,
the 1958 Nobel Physics Laureate who first characterized it
rigorously [1]. If the speed of a charged and high-energy particle is
faster than the speed of light in a dielectric medium, visible and
near-infrared photons are emitted [1,2,3]. At that time, it was not
applied to biomedical imaging since the optical signals were too
weak to be detected due to the limitation of the optical detection
devices.
With the development of the highly sensitive charge-coupled
device (CCD) camera, Cerenkov radiation has been applied to
in vivo optical imaging of small living animals in recent years [4–
16]. Robertson et al. first presented in vivo Cerenkov luminescence
imaging (CLI) in mice using a highly sensitive CCD camera [4].
Spinelli et al. presented a detailed model of the Cerenkov radiation
spectrum considering the positron energy spectrum to quantify the
amount of light emission [5]. In vivo optical imaging of radiotracers
that emit charged particles such as b
+ or b
– has also been
demonstrated in succession [6]. Presently, the studies of in vivo CLI
in small living animals mainly focus on 2D imaging [4–13].
However, the 2D images cannot provide the depth and
quantitative information of the radionuclide tracer. Li et al.
presented 3D Cerenkov luminescence tomography (CLT) based
on a homogeneous mouse model using multiple views [14].
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e37623Multiple views could reduce the ill-posedness of the inverse
problem and improve the reconstruction equality of single-spectral
CLT [14]. However, the acquisition of multiple views increases the
complexity of the experiment. And the hypothesis of a homoge-
neous optical parameter will lead to inaccurate source reconstruc-
tion results [17,18]. In our previous study, we performed in vivo 3D
CLT based on a heterogeneous mouse model with an implanted
Na
131I radioactive source [15]. Our results showed that the
reconstruction based on a heterogeneous mouse model was more
accurate in localization than using the homogeneous one [15].
Nevertheless, the reconstruction results were not very encouraging
based on a single spectrum 675–775 nm because CLT is a very
challenging ill-posed inverse problem. Spinelli et al. described a
multispectral diffuse CLT (msCLT), which was based on a set of
2D planar images acquired using a number of narrow bandpass
filters [16]. Multispectral data could effectively improve the ill-
posedness of the inverse problem; however an increase in the
known data also reduces the reconstruction efficiency [19]. On the
other hand, compared with the other optical molecular imaging,
the in vivo Cerenkov luminescent signal is weak when the
radiopharmaceutical is at a safe injection dose. Hence, the
detected multispectral data will be weaker after using more than
one filter, which will increase the difficulty of the source
reconstruction. Furthermore, the use of a number of filters to
obtain 2D planar images for 3D reconstruction costs more
acquisition time.
In this paper, we presented a semi-quantitative Cerenkov
radiation spectral characteristic-based Cerenkov luminescent
source reconstruction method called hybrid spectral CLT, which
was based on a single 2D planar image. It was unnecessary to use
filters to acquire luminescent images, yet the information about
wavelengths was incorporated in the reconstruction process, thus
more encouraging results were obtained. We constructed the
implantation mouse model implanted with a 400 mCi Na
131I
radioactive source and the physiological mouse model received an
intravenous tail injection of 400 mCi radiopharmaceutical Iodine-
131 (I-131) to validate the performance of the hybrid spectral CLT
and compared the reconstruction results, acquisition and image
reconstruction time with that of single-spectral and multispectral
CLT. Results showed that the reconstruction based on the hybrid
spectral CLT was more accurate in localization and quantification
than using single-spectral CLT, and was more efficient in the
in vivo experiment compared with multispectral CLT. Based on the
hybrid spectral reconstruction method, we performed 3D nonin-
vasive, longitudinal observations of I-131 uptake in the thyroid
and quantified I-131 uptake in vivo by means of hybrid spectral
CLT/CT. The results were consistent with SPECT imaging and
the ex vivo biodistribution experiment further verified the results of
hybrid spectral CLT.
Results
Spectral Characteristics of the Na
131I Radioactive Source
To perform hybrid spectral CLT, the spectral characteristics
of the Na
131I radioactive source with various activities were
investigated. The measured spectra of the emitted luminescence
from the Na
131I radioactive sources presented a broad
distribution from 500 nm to 900 nm, and the optical signals
emitted from the Na
131I radioactive sources decreased with
increasing wavelength (Fig. 1), which was consistent with our
previous findings [15]. The spectrum presented a
1=l
2dependence [3,4]. We found that the percentages of optical
signal intensity at four different discrete spectrum ranges
including 515–575 nm, 575–650 nm, 695–770 nm and 810–
875 nm were approximately 0.572, 0.276, 0.124, and 0.028
respectively. They were used in hybrid spectral CLT. Further-
more, the proportions were irrelevant to the activity of the
Na
131I radioactive sources. Hence, we can reconstruct Na
131I
with various activities using hybrid spectral CLT.
Hybrid Spectral CLT of the Implantation Mouse Model
The luminescent image of the mouse implanted with the
400 mCi Na
131I radioactive source was acquired without using
filters, which is in pseudo-color superimposed on the correspond-
ing photograph (Fig. 2A). We observed optical signals in the
abdomen of the mouse. The absorption coefficient and reducing
scattering coefficient of the mouse biological tissues are calculated
and listed in Table 1. Using the previously described semi-
quantitative Cerenkov radiation spectral characteristic-based
source reconstruction method, the 3D distribution of the internal
implanted Na
131I radioactive source was reconstructed and shown
in 3D rendering (Fig. 2B). In order to analyze the results
quantitatively, we defined the distance error
d~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
(x{x0)
2z(y{y0)
2z(z{z0)
2
q
, where (x,y,z) is the coordi-
nate of the reconstructed source with maximum density, and
(x0,y0,z0) is that of the actual source. The reconstructed energy is
defined as Srecon~
P
½( 1
4|(
P
phantom point(node,4)))|V ,
where the phantom point(node,4) is the density of the tetrahedral
nodes, and V is the volume of the tetrahedron. The activity of the
source can be calculated through the linear relationship between
the reconstructed energy and the source’s activity
(y~{0:00648z4:56574E{5   x,r2~0:9365) (as shown in Fig-
ure S1). The purple object similar to a cylinder was the implanted
radioactive source and the coordinates could be obtained via
micro-CT images as (115.84, 107.24, 30.00) mm. The recon-
structed source was a cluster of tetrahedrons because of the
tetrahedral mesh generation. The reconstructed sources are clearly
Figure 1. The measured spectra of the emitted luminescence
from the Na
131I radioactive sources. Na
131I radioactive sources
(n~6) were made of glass vessels filled with Na
131I and were acquired
for luminescent images by using the standard filter set installed on the
IVIS system including 515–575 nm (GFP), 575–650 nm (DsRED), 695–
770 nm (Cy5.5) and 810–875 nm (ICG). The activities of Na
131I were
100 mCi, 200 mCi, 300 mCi, 400 mCi, 500 mCi and 600 mCi respectively.
The percentages of optical signal intensity at four different discrete
spectral ranges were approximately 0.572, 0.276, 0.124, and 0.028
respectively. Spectral energy distribution of the emitted light from the
Na
131I radioactive source with various activities is shown in Fig. 1.
doi:10.1371/journal.pone.0037623.g001
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source was (115.79, 107.57, 30.59) mm, the distance error was
0.68 mm and the reconstructed source energy was 1.11610
22 nw.
The reconstructed source activity was 386 mCi and the activity
error was 3.51% (Table 2).
Single-spectral CLT and Multispectral CLT of the
Implantation Mouse Model
To compare the reconstruction results of hybrid spectral CLT
with that of single-spectral CLT and multispectral CLT, we
reconstructed the 3D distribution of the internal implanted
radioactive source based on the single spectrum and multispectral
measurement data respectively.
The four luminescent views in pseudo-color superimposed on
the corresponding photographs of the same mouse were acquired
from a set of four filters installed on the IVIS system (Fig. 2C). The
maximum optical signal was observed when the 695–770 nm filter
was used. The second was observed for the 575–650 nm filter, the
third for the 515–575 nm filter, and the optical signal was the
lowest when the 810–875 nm filter was used. The reconstruction
Figure 2. Hybrid spectral, multispectral and single-spectral CLT of a mouse implanted with a Na
131I radioactive source. Fig. 2(A) is the
single luminescent image of the athymic nude mouse implanted with the 400 mCi Na
131I radioactive source without using filters, which is in pseudo-
color superimposed on the corresponding photograph. Fig. 2(B) shows the 3D rendering of the reconstruction results of hybrid spectral CLT based on
the single luminescent image. Fig. 2(C) consists of multispectral measurements of the mouse with the implanted 400 mCi Na
131I radioactive source
acquired by a set of four filters including 515–575 nm, 575–650 nm, 695–770 nm and 810–875 nm filters respectively. Fig. 2(D) has the 3D rendering
of the reconstruction results based on the multispectral measurements. The 3D renderings of the reconstructed source distribution based on the four
single spectra as shown in Fig. 2(E), including 515–575 nm, 575–650 nm, 695–770 nm and 810–875 nm respectively.
doi:10.1371/journal.pone.0037623.g002
Table 1. Optical parameters for the mouse organ regions.
Coefficient Adipose Heart Lungs Liver Stomach Kidneys Bone Spleen Bladder Intestines
ma mm{1   
0.1017 1.5477 4.6832 9.2860 0.3082 1.7334 1.5233 9.2860 0.1017 0.2891
m
0
a mm{1   
1.2929 1.1674 2.3271 0.7786 1.6320 2.7599 3.0393 0.7786 1.2929 1.3548
doi:10.1371/journal.pone.0037623.t001
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3D rendering (Fig. 2D). The location of the reconstructed source
was (115.38, 107.57, 29.82) mm, the distance error was 0.59 mm,
the reconstructed source energy was 1.13610
22 nw, the recon-
structed source activity was 390 mCi and the activity error was
2.46% (Table 2).
The reconstruction results based on the above four single
spectra were shown in 3D rendering (Fig. 2E). The distance
error of single-spectral CLT was 2.8460.57 mm. The located
deviation based on the 810–875 nm spectrum was 2.30 mm,
which was the lowest amount for all of the reconstruction
results. All of the reconstructed energy based on the four single
spectra was very inaccurate and the activity error was
161.8660.20% (Table 2). It was obvious that the reconstruction
results in localization and quantification based on the multi-
spectral measurements were more accurate than those based on
single spectral data.
Through the comparisons of the reconstruction results of the
hybrid spectral CLT and that of single-spectral CLT, these data
demonstrated the results of hybrid spectral CLT which were
more accurate in the reconstructed location and quantification
than that of single-spectral CLT. Compared with multispectral
CLT, the distance error of hybrid spectral CLT was a little
larger than that of multispectral CLT, and it was a little less
accurate in quantification than multispectral CLT. Furthermore,
we compared the acquisition and image reconstruction time
with these methods, and the results are shown in Table 3.
There was not a large difference in both the acquisition and
image reconstruction time between hybrid spectral CLT and
single-spectral CLT. For multispectral CLT, its acquisition time
was four times as that of hybrid spectral CLT, and image
reconstruction time was about 41 times slower than hybrid
spectral CLT. Integrating the reconstruction results and
required time, the hybrid spectral CLT showed better perfor-
mance than the two other methods.
Hybrid Spectral CLT of I-131 Uptake in the Bladder of the
Physiological Mouse Model
We observed optical signals in the neck and abdomen of the
mouse two hours after the intravenous tail injection with 400 mCi
I-131 (Fig. 3A). To confirm the performance of hybrid spectral
CLT in a realistic and more biologically representative mouse
model, we also acquired multispectral luminescent images of the
mouse using four filters, including 580–40 nm, 620–40 nm, 660–
40 nm, and 700–40 nm. A very weak optical signal was obtained
using the 700–40 nm filter, and almost no signal was acquired by
using the other filters (Fig. 3B).
We then performed the 3D reconstruction of I-131 uptake in
the mouse bladder using hybrid spectral CLT. Optical
parameters of biological tissues used in the reconstruction are
listed in Table 1. Reconstructed I-131 was clearly distributed in
the mouse bladder in the 3D radiopharmaceutical I-131
biodistribution rendering of the heterogeneous mouse model
(Fig. 3C). The geometrical center of the bladder was defined as
the actual source location, which could be obtained by micro-
CT images at (18.24, 25.76, 3.68) mm. The location of the
reconstructed source was (18.86, 27.04, 3.54) mm, the distance
error between the actual source and the reconstructed one was
1.43 mm, the reconstructed total energy of I-131 was
1.34610
24 nw, and the reconstructed source activity was
145 mCi (Table 4). Nuclear signals appeared in the mouse
bladder in SPECT imaging (data not shown), which was
approximately consistent with that of hybrid spectral CLT.
The reconstruction results of hybrid spectral CLT and single-
spectral CLT based on the 700–40 nm spectrum were in
horizontal, coronal, and sagittal views across the geometric center
of the bladder respectively (Fig. 3D and E). It was clear that the
reconstructed location of hybrid spectral CLT was more accurate
than that of single-spectral CLT. For single-spectral CLT, the
distance error between the actual source and the reconstructed
one was 4.64 mm, the total energy of the reconstructed source was
1.02610
23 nw, and the reconstructed source activity was 164 mCi
(Table 4). Results showed that hybrid spectral CLT could
accurately reconstruct the I-131 uptake in the mouse bladder
and was more applicable than multispectral CLT in the in vivo
experiment.
Table 2. The reconstruction results for the implantation mouse model based on hybrid spectral CLT, single-spectral CLT and
multispectral CLT.
Spectrum
Actual source
center (mm)
Reconstructed source
location (mm)
Located
deviation (mm)
Reconstructed
energy (610
25 nw)
Activity
errors %
Hybrid spectral (115.84, 107.24, 30.00) (115.79, 107.57, 30.59) 0.68 1114.30 3.51
515–575 nm (115.84, 107.24, 30.00) (115.24, 109.89, 28.20) 3.26 3.15 179.60
575–650 nm (115.84, 107.24, 30.00) (116.12, 108.43, 27.93) 2.40 6.85 178.03
695–770 nm (115.84, 107.24, 30.00) (118.77, 105.53, 30.05) 3.40 101.72 142.95
810–875 nm (115.84, 107.24, 30.00) (115.05, 105.18, 29.37) 2.30 89.81 146.85
Multispectral (115.84, 107.24, 30.00) (115.38, 107.57, 29.82) 0.59 1134.53 2.4564
doi:10.1371/journal.pone.0037623.t002
Table 3. Comparisons of hybrid spectral CLT, single-spectral
CLT and multispectral CLT based on the acquisition and
image reconstruction time.
Acquisition time
(min)
Image
reconstruction time
(min)
Hybrid spectral 5 5.24
695–770 nm 5 4.87
575–650 nm 5 4.74
515–575 nm 5 4.72
810–875 nm 5 4.92
Multispectral 20 218.12
doi:10.1371/journal.pone.0037623.t003
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Radiopharmaceutical I-131 Uptake in the Thyroid and the
Quantification of I-131 Uptake in vivo using Small Animal
Hybrid Spectral CLT/CT
We observed optical signals in the mouse neck from the 2D
planar luminescent images obtained at 0.5 h, 1 h, 3 h, 12 h,
and 24 h after the intravenous tail injections of 450 mCi I-131
(Fig. 4A). We performed a 3D noninvasive longitudinal
observation of I-131 uptake in the thyroid and the quantifica-
tion of I-131 uptake in vivo by means of hybrid spectral CLT
(Fig. 4B). The reconstructed energy reflected the I-131 uptake in
the thyroid. I-131 uptake increased with the collection time
point and its maximal energy appeared at 24 h (Table 5). The
3D distribution of I-131 at 24 h after the injection using hybrid
spectral CLT is shown in Fig. 5A. The reconstruction results in
horizontal, coronal, and sagittal views show the I-131 uptake in
the thyroid (Fig. 5B). Nuclear signals were observed in the
Figure 3. The biodistribution of I-131 uptake in the mouse bladder of hybrid spectral CLT. An athymic nude mouse received the
intravenous tail injection of 400 mCi I-131. Fig. 3(A) is the single luminescent image of the mouse 2 h after the injection which was acquired without
using filters; this is depicted in pseudo-color superimposed on the corresponding photograph. The luminescent image of the mouse using the 700–
40 nm filter is shown in Fig. 3(B) where there is almost no optical signal when using the other filters including 580–40 nm, 620–40 nm, and 660–
40 nm. Fig. 3(C) is the 3D radiopharmaceutical I-131 biodistribution rendering of hybrid spectral CLT. Fig. 3(D) and (E) are the reconstruction results in
horizontal, coronal, and sagittal views of the hybrid spectral CLT and the single-spectral CLT based on the 700–40 nm spectrum.
doi:10.1371/journal.pone.0037623.g003
Table 4. The reconstruction results of I-131 uptake in the mouse bladder using hybrid spectral CLT and single-spectral CLT.
Actual source
center (mm)
Reconstructed source
location (mm)
Located
deviation (mm)
Reconstructed
energy (610
25 nw)
Activity
(mCi)
Hybrid spectral CLT (18.24, 25.76, 3.68) (18.86, 27.04, 3.54) 1.43 13.43 145.31
Single-spectral CLT (18.24, 25.76, 3.68) (20.40, 29.86, 3.77) 4.64 102.12 164.73
doi:10.1371/journal.pone.0037623.t004
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after the injection (data not shown), which was similar to hybrid
spectral CLT.
The reconstructed energy of the I-131 uptake in the thyroid
increased with increasing collection time points and maximal
energy appeared at 24 h (Fig. 6A (red line)). The gamma ray
counts of the I-131 uptake in the thyroid increased with increasing
collection time points (Fig. 6A (blue line)). There was a robust
correlation between the reconstructed energy of I-131 versus the
gamma ray counts of I-131 (r2~0:8240) (Fig. 6B). This indicated
the capacity of hybrid spectral CLT for quantifying the I-131
uptake in the thyroid compared with SPECT imaging.
The mouse was dissected at 24 h after the intravenous tail
injection of 450 mCi I-131, and the mouse organs included the
heart, lungs, liver, stomach, kidneys, bladder, spleen, intestines,
and thyroid (Fig. 7A). The optical signals were observed in the
mouse thyroid and there were no signals in the other mouse organs
(Fig. 7B). It stated clearly that the radiopharmaceutical I-131
biodistribution occurred in small living animals. Fig. 7C is the
nuclear imaging of the mouse organs. The thyroid was clearly
imaged but other mouse organs were not. The results of CLI of the
mouse organs were concurrent with that of SPECT imaging. The
ex vivo biodistribution experiment further confirmed the I-131
uptake in the thyroid of hybrid spectral CLT.
Our data indicated that hybrid spectral CLT combined with
small animal CT can be used for 3D noninvasive longitudinal
monitoring of I-131 uptake in the thyroid and the quantification of
I-131 uptake in vivo.
Discussion
Multispectral imaging can reduce the ill-posedness of the inverse
problem in CLT and significantly improve the reconstruction
quality. An increase in the known data also reduces the
reconstruction efficiency because the dimension of the Jacobian
matrix becomes very large for most iteration-based algorithms
[19]. On the other hand, the Cerenkov luminescent signal is very
weak when the radiopharmaceutical has a low radiation dose.
Hence, it is difficult to obtain multispectral data using filters.
Furthermore, the use of a number of filters to obtain 2D planar
images for 3D reconstruction requires more acquisition time. In
this paper, we present a semi-quantitative Cerenkov radiation
spectral characteristic-based source reconstruction method for
CLT known as hybrid spectral CLT, which is based on a single 2D
planar image acquired without using filters. The reconstruction
results of the implanted Na
131I radioactive source demonstrated
greater accuracy in location and quantification of hybrid spectral
CLT than for single-spectral CLT. Compared with multispectral
CLT, the distance error of the hybrid spectral CLT was 0.68 mm,
which was slightly larger than for multispectral CLT, and it was a
little less accurate in quantification than multispectral CLT.
However, the results were encouraging. The acquisitions and
image reconstruction time can be greatly shortened simultaneous-
ly. In addition, the biodistribution results of I-131 uptake in the
mouse bladder showed the ability of hybrid spectral CLT to locate
the position correctly and the superiority for the reconstruction of
the weak Cerenkov luminescent signal compared with multispec-
tral CLT. Hybrid spectral CLT does not need to use filters for
Figure 4. Noninvasive longitudinal observations of I-131 uptake in the thyroid using CLI and 3D CLT. Fig. 4(A) shows the 2D
luminescent images of I-131 uptake in the athymic nude mouse thyroid at 0.5 h, 1 h, 3 h, 12 h, and 24 h after the intravenous tail injections of
450 mCi of I-131. Fig. 4(B) portrays 3D noninvasive longitudinal observations of I-131 uptake in the thyroid and the quantification of I-131 uptake
in vivo using small animal hybrid spectral CLT/CT.
doi:10.1371/journal.pone.0037623.g004
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wavelengths was incorporated into the reconstruction process.
Hence, more encouraging results were obtained without increas-
ing acquisition time.
The spectral distribution characteristics of the Na
131I radioac-
tive source with various activities were investigated, which was
important for the Cerenkov source reconstruction in hybrid
spectral CLT. Experimental results suggested that the percentages
of optical signal intensity at the four different discrete spectrum
ranges were irrelevant to the activity of the Na
131I radioactive
sources. Thus, we can reconstruct the radionuclide tracer with
various activities of the hybrid spectral CLT. Additionally, we
speculated that the percentages possibly had no relevance with the
variety of radionuclide tracers according to the spectral distribu-
tion of various radionuclide tracers [6]. Consequently, it was very
convenient to reconstruct the 3D biodistribution of various
radionuclide tracers in small living animals using the hybrid
spectral CLT without computing the optical parameters during
the reconstruction process and using any filters for acquiring
images.
The choice of implanting an 131-I source in an animal is not at
all physiological, so in order to verify the performance of hybrid
spectral CLT in a real in vivo experiment, we performed a much
easier, but at the same time more elegant, realistic and more
biologically oriented solution for imaging I-131 uptake in the
mouse bladder. Based on hybrid spectral CLT, the located
deviation of the I-131 uptake in the mouse bladder was 1.43 mm.
For single-spectral CLT, the distance error was 4.64 mm.
Figure 5. The CLT of athymic nude mice at 24 h after injection. The athymic nude mouse received the intravenous tail injection of 450 mCi I-
131. Fig. 5(A) is the 3D rendering of the I-131 uptake in the thyroid using hybrid spectral CLT at 24 h post-injection. Fig. 5(B) has the reconstruction
results of hybrid spectral CLT of I-131 uptake in the thyroid at 24 h after the injection in horizontal, coronal, and sagittal views respectively.
doi:10.1371/journal.pone.0037623.g005
Table 5. The reconstructed energy and activity of I-131 uptake in the thyroid at collection time points.
Collection time points (h) Reconstructed energy (610
25 nw) Activity (mCi)
0.5 81.628 160.24
1 117.51 168.10
3 147.92 174.76
12 204.6 187.18
24 324.65 213.47
doi:10.1371/journal.pone.0037623.t005
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accurately reconstruct I-131 uptake in the mouse bladder. Here,
we could not perform multispectral CLT due to the non-
acquisition of multispectral measurements. It showed that hybrid
spectral CLT was more applicable than multispectral CLT in the
in vivo experiment.
The located deviation of the implanted radioactive source was
0.68 mm,andthelocateddeviationoftheI-131uptakeinthemouse
bladder was 1.43 mm, which was worse than in the implantation
mousemodel.Itwasprobablyduetotheuseoftheimplantedpoint-
like Cerenkov source which assisted in the convergence of the
reconstruction algorithm.
As we all know, the thyroid gland situated in the anterior neck
below the skin and muscle layers is the biggest gland in the neck. It
takes the shape of a butterfly with the two wings being represented
by the left and right thyroid lobes. The function of the thyroid is to
regulate the body’s metabolism. In clinics, the thyroid scan is
employed to determine the position, shape and size of the thyroid
gland and the thyroid uptake is used to estimate the function of the
gland. Iodine concentrates in the thyroid. This is the basis for
morphological and functional imaging. The physical half-life of I-
131 radiotracer is 8.04 day, the maximal energy of beta particles is
0.606 MeV, and the energy of c rays is 0.364 MeV. It satisfies the
threshold energy for the production of Cerenkov radiation in
tissues [4]. Based on Cerenkov radiation, we performed a 3D
noninvasive longitudinal observation of I-131 uptake in the
thyroid by means of hybrid spectral CLT/CT. The 3D
visualization of longitudinal observations clearly showed that
there was I-131 uptake in the thyroid and that the reconstructed
energy of I-131 uptake in the thyroid increases with acquisition
time. The reconstructed location of I-131 was not verified because
the mouse thyroid was similar to connective tissue, meaning that
CT could not distinguish it from the surrounding tissues.
Nevertheless, it was roughly affirmed by SPECT images.
Furthermore, in the ex vivo biodistribution experiment, the optical
signals were observed in the mouse thyroid and there were no
signals in the other mouse organs, which was concurrent with the
nuclear images (Fig. 7B). It further confirmed I-131 uptake in the
thyroid for hybrid spectral CLI.
WequantifiedradiopharmaceuticalI-131uptakeinthethyroidin
vivo using hybrid spectral CLT/CT. There was a robust correlation
between the reconstructed energy of I-131 versus the gamma ray
Figure 6. The correlation analysis between hybrid spectral CLT and SPECT. The reconstructed energy of I-131 uptake in the thyroid as a
function of the collection time point is described in Fig. 6(A) (red line). The gamma ray counts of I-131 uptake for SPECT imaging as a function of the
collection time point is depicted in Fig. 6(A) (blue line). There was a robust correlation between the reconstructed energy of I-131 versus the gamma
ray counts of I-131 (r2~0:8240) as shown in Fig. 6(B).
doi:10.1371/journal.pone.0037623.g006
Figure 7. The ex vivo biodistribution experiment of the mouse. The mice received euthanasia and dissection at 24 h after the intravenous tail
injections of 450 mCi I-131. Fig. 7(A) and (B) are the photographs and luminescent images of the mouse organs, including the heart, lungs, liver,
stomach, kidneys, bladder, spleen, intestines, and thyroid respectively. The optical signals were observed in the mouse thyroid and there were no
signals in the other mouse organs (Fig. 7(B)). Fig. 7(c) is the nuclear imaging of the mouse organs. The thyroid was clearly imaged but other mouse
organs were not.
doi:10.1371/journal.pone.0037623.g007
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potentialofhybridspectralCLTforclinicalapplicationinthefuture,
suchasdeterminingthyroidsize,function,andposition,quantitative
thyroid uptake, treatment of hyperthyroidism and cancer, and
detectionofthyroidmetastasesandassessmentofresponsetotherapy.
Compared with nuclear imaging, it has more advantages, such as
having alowercost ofusinganoptical instrument,highthroughput,
andhighspecificity.Therefore,weanticipatethatCLTcouldbeused
inclinics inthe future.
Normally, our imaging object is a mouse model, but for bigger
imaging objects, such as the size of larger animals or humans, our
proposedalgorithmwouldencountersomedifficulties.Firstly,dueto
the intrinsic spectral and intensity limitation of the Cerenkov
luminescencesignalintheanimalmodel,whichisunabletopenetrate
the thick biological tissue and be detected with a highly sensitive
charged coupled device. Furthermore, the existing optical coeffi-
cients in this manuscript were calculated according to the literature
[18]. We could not find more comprehensive optical coefficients for
large animals, which will induce great
difficulties for heterogeneous reconstruction. Additionally, the
acquisitionoflargeanimalswillbringalargeamountofdata.Limited
bythecurrentcomputerhardwaretechnology,theinversionofalarge
matrix is a difficult problem for source reconstruction.
In order to provide a comparison with conventional SPECT
imaging, we used a SPECT-CT system with poor spatial
resolution. This is a suboptimal imaging procedure for small
animal imaging. However, the most important point to make here
is that fused SPECT-CT images were used to roughly compare
them with reconstructed Cerenkov images. In later research, we
will consider developing an animal multimodality CLT/SPECT/
CT system to perform the biomedical applications.
In this paper, we revisited the problem of reconstructing the 3D
radiopharmaceutical biodistribution in small living animals in
CLT. We have presented a modified reconstruction method based
on Cerenkov radiation spectral characteristics to efficiently
reconstruct the biodistribution of the radionuclide tracer. It does
not have to use filters for acquiring luminescent images for
reconstruction; however, the information about wavelengths was
incorporated into the reconstruction process. Hence, the more
encouraging results were obtained without increasing acquisition
time. We have experimented on an implantation mouse model
and a physiological mouse model and compared our method and
results with single-spectral and multispectral CLT. Furthermore,
we performed 3D noninvasive longitudinal monitoring of I-131
uptake in the thyroid and quantified I-131 uptake in vivo by means
of small animal hybrid spectral CLT/CT. Our study showed that
our approach was efficient in reconstructing the biodistribution of
the radionuclide tracer, and 3D visualization of I-131 uptake in
the thyroid suggested a linear relationship between the recon-
structed energy of CLT and the gamma ray counts for SPECT
which could provide more quantitative information. We believe
that our approach delivers valuable information and provides an
excellent tool that facilitates more detailed exploration for CLT
clinical application.
Materials and Methods
All animal procedures were in accordance with the Fourth
Military Medical University (FMMU) approved animal protocol.
Preparation of Radioactive Sources
Na
131I radioactive sources (n~6) were made of glass vessels filled
with Na
131I. The activities were 100 mCi, 200 mCi, 300 mCi,
400 mCi, 500 mCi and 600 mCi respectively. The volume of the
Na
131I radioactive source was about 13 mm
3 and the solvent of
the radioactive source was normal saline. The dimensions of the
columniform glass vessel were approximately 3.42 mm in diameter
and7 mminlength.Acontrolsourcewasfilledwithanonradioactive
NaI solution.
Establishment of the Implantation Mouse Models and
the Physiological Mouse Models
The implantation mouse models were established by implanting
a 400 mCi Na
131I radioactive source into an athymic nude mouse
belly (n~3, weight 1663 g). The mice underwent aseptic
celiotomy and the depth of the embedded radioactive source
was approximately 4 mm from the top surface of the mouse. The
athymic nude mice (n~3, weight 1763 g) received an intravenous
tail injection of 400 mCi I-131 to construct the physiological mouse
models. The athymic nude mice (n~3, weight 2262 g) received
intravenous tail injections of 450 mCi I-131 and were used for the
3D noninvasive, longitudinal observations of I-131 uptake in the
thyroid using hybrid spectral CLT. In the experiment, the mice
were anesthetized using isoflurane (2%).
Cerenkov Luminescence Imaging and CT Imaging
To investigate the spectral characteristic of the emitted light
from the Na
131I radioactive sources with various activities, the
previously described Na
131I radioactive sources (n~6) were
imaged for acquiring optical signals with the Xenogen In Vivo
Imaging System (IVIS Kinetic, Caliper Life Sciences) using four
filters installed on the IVIS system including 515–575 nm (GFP),
575–650 nm (DsRED), 695–770 nm (Cy5.5) and 810–875 nm
(ICG). Regions of interest (ROIs) of the same area were drawn
over the optical images of the six radioactive sources, and the
average radiances were read by Living Image 3.2 software (IVIS
Kinetic, Caliper Life Sciences), which provided the intensities of
the optical signals.
To reconstruct the implanted 400 mCi Na
131I radioactive
source using hybrid spectral CLT, the mice (n~3) with the
implanted 400 mCi Na
131I radioactive source were acquired for a
single luminescent image by the IVIS system without using any
filters. Comparing single-spectral CLT and multispectral CLT, the
mice were also acquired for multispectral images using the
previously described four filters. All luminescent images were
acquired with a binning value of 4, integration time of 5 min and
aperture number fnum=1.
To reconstruct the I-131uptake inthe bladder, the athymicnude
mice (n~3) were affixed in an animal-imaging holder in a vertical
positiontwohourslateraftertheintravenoustailinjectionof400 mCi
I-131 and imaged for a single luminescent image of the mouse
abdomenwithadual-modalityZKKS-Direct3Dmolecularimaging
system(jointlydevelopedbyGuangzhouZhongkeKaishengMedical
Technology CO., Ltd, Xidian University and Institute of Automa-
tion, CAS). To compare the results of the hybrid spectral CLT with
single-spectral and multispectral CLT, the mice were then imaged
using a number of filters including 580–40 nm, 620–40 nm, 660–
40 nm, and 700–40 nm.
For performing 3D longitudinal observations of I-131 uptake in
the thyroid, athymic nude mice (n~3) were acquired for
luminescent images of the mouse neck at 0.5 h, 1 h, 3 h, 12 h,
and 24 h after the intravenous tail injections of 450 mCi I-131
using the dual-modality ZKKS-Direct3D molecular imaging
system. To further confirm the I-131 uptake in the thyroid
through the ex vivo experiment, the mice were euthanized and
dissected at 24 h after the intravenous tail injections of 450 mCi I-
131. The mouse organs, including the heart, lungs, liver, stomach,
kidneys, bladder, spleen, intestines, and thyroid were acquired for
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binning value of 4, integration time of 5 min and aperture number
fnum=2.8.
In order to perform the 3D reconstruction of the radiopharma-
ceutical biodistribution in the living mouse, both the athymic nude
micewhoreceivedintravenoustailinjectionsof400 mCiofI-131and
the athymic nude mice who received intravenous tail injections of
450 mCi of I-131 were scanned for acquiring structural information
bythedual-modalityZKKS-Direct3Dmolecularimagingsystemin
the same vertical position as the optical imaging immediately after
celiacadministrationofthecontrastmaterialdiatrizoatemeglumine
injection usingthefollowing imaging parameters:50 kVand 1 mA.
Toacceleratethespeedof3Dcomputedtomographyreconstruction,
theFeldkamp-Davis-Kress(FDK)algorithmonthecommodityGPU
usinganaccelerationschemewasemployedforthe3Dreconstruction
ofCTimages[20].Thealgorithmperformedthereconstructionona
25662566256 volume(160 mm6160 mm6160 mm voxel size).
SPECT/CT Imaging
To compare CLT images with SPECT images, the athymic
nude mice (n~3) with the intravenous tail injections of 400 mCi I-
131 immediately underwent SPECT imaging after CLT. In the
longitudinal observation experiment of I-131 uptake in the
thyroid, the athymic nude mice (n~3) were immediately acquired
for nuclear images after CLT at 0.5 h, 1 h, 3 h, 12 h, and 24 h
after the intravenous tail injections of 450 mCi I-131. SPECT
imaging was performed with the SPECT-CT system (Symbia T2,
Siemens) using the following imaging parameters: 64 frames,
64664 pixels and zoom=1. To perform the correlation analysis
between the hybrid spectral CLT and SPECT, the planar SPECT
images were acquired with the parameters: 1286128 pixels and
zoom=1. ROIs were drawn over the nuclear images to acquire c
counts. In the experiment, the mice were affixed on the hardboard
in the supine position using adhesive tape. For acquiring structural
information, the mice were scanned with the CT system after the
intravenous tail injections with contrast media.
The Semi-quantitative Cerenkov Radiation Spectral
Characteristic-based Cerenkov Luminescent Source
Reconstruction Method
The propagation of Cerenkov photons in biological tissues can
be described by the steady-state diffusion equation (DE) and Robin
boundary condition as follows [21–25]:
{+:(D(x)+W(x))zma(x)W(x)~S(x)( x[V) ð1Þ
W(x)z2A(x;n,n
0
)D(x)(v(x):+W(x))~0( x[LV) ð2Þ
The related parameters are detailed in Ref. [21–25].
Based on the finite element theory, a linear relationship between
the Cerenkov luminescent source and the measured Cerenkov
signal on the body surface can be described as follows:
M(ma(l),D(l))S~WB ð3Þ
where M(ma(l), D(l)) is the system matrix which is related to the
tissue optical properties; WB represents the nodal flux density at the
boundary.
Presently, both single spectral and multispectral methods were
employed for the solution of S. In single-spectral CLT, the
equation can be expressed as follows:
M(ma(l0),D(l0))S~WB ð4Þ
The optical parameters are usually calculated based on l0,
which is the center wavelength of the band pass filter used in data
acquisition.
In multispectral CLT, equation (3) can be expressed as follows:
M1(m(l1),D(l1))
M2(m(l2),D(l2))
. .
.
MN(m(lN),D(lN))
2
6 6 6 6 4
3
7 7 7 7 5
S~
WB
1
WB
2
. .
.
WB
N
2
6 6 6 6 6 4
3
7 7 7 7 7 5
ð5Þ
where l1,l2,:::,lN are the center wavelengths of a number of band
pass filters which are used in the multispectral data acquisition;
M1,M2,:::,MN represent the system matrix of the different spectra
l1,l2,:::,lN respectively; and WB
1,WB
2,:::,WB
N denote the nodal flux
density at the boundary of different spectra l1,l2,:::,lN.
In single-spectral CLT, the optical parameters are calculated
according to the certain wavelength of the band pass filter, which
cannot accurately describe the photon propagation in biological
tissues. Additionally, it is difficult to acquire a weak Cerenkov
luminescence signal using a filter. For multispectral CLT, the
multispectral data could effectively improve the ill-posedness of the
inverse problem because the acquisition of multispectral informa-
tion increases the amount of known boundary measurements.
However, the increase of computational cost significantly reduces
the reconstruction efficiency. More importantly, since the emitted
light from the Cerenkov luminescent source is quite weak, the
usage of a number of filters may increase the difficulty to obtain
the multispectral measurements. Furthermore, the acquisition of
multispectral data using a number of filters requires greater
acquisition time.
On the basis of the above analysis, we presented a modified
CLT named hybrid spectral CLT to reconstruct the biodistribu-
tion of the radionuclide tracer. In our method, data in the entire
spectrum of the Cerenkov signals were employed in the
reconstruction of the Cerenkov source. The optical parameters
of the tissues over the entire spectrum were estimated based on the
spectral characteristics of the Cerenkov source and could be
determined as follows:
~ m ma~
X N
n~1
cnma(tn) ð6Þ
~ D D~
X N
n~1
cnD(tn) ð7Þ
where ~ m ma is the estimated absorption coefficient in the entire
spectrum of Cerenkov light; ~ D D is the related diffusion coefficient;
N is the number of spectra for reconstruction; here, N~4;
tn~½ln{1,ln ,n~1,2,:::,N; and cn is the percentage of optical
signal intensity at N different discrete spectral ranges and can be
calculated by the measured spectra of the emitted luminescence
from the radionuclide tracer.
Thus, Eq. (3) can be converted into the following formula in our
proposed method:
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where ~ M M is the system matrix based on the hybrid spectral
measurements; ~ W WB is the measured Cerenkov light without any
filters.
Applying the adaptive hp strategy [26], Eq. (8) can be
transformed to the following equation:
~ M MkS
p
k~~ W WB
k ð9Þ
where ~ M Mk is the system matrix for the k-th level mesh which is
related to the estimated optical properties; S
p
k is the Cerenkov light
source distribution located in the permissible source region that is
determined by a priori knowledge; and ~ W WB
k is the nodal flux density
on the surface. In the mouse experiments, the surface nodal flux
density was obtained by mapping the measured 2D Cerenkov
images onto the 3D body surface [27].
Because of the ill-posed nature of CLT, it is difficult to solve Eq.
(9) directly. The classical Tikhonov regularization method can be
used to solve Eq. (9). The following optimization problem is
defined to determine the Cerenkov light source distribution:
min
SinfƒSp
kƒSsup
H(S
p
k)~ ~ M MkS
p
k{~ W WB
k
       
L2(V)zlk S
p
k
       
L2(V) ð10Þ
where Sinf and Ssup are the lower and upper bounds of the
Cerenkov light source power density and lk denotes the
regularization parameter. L2(V) is the weight matrix and satisfies
V kk L2(V)~VTL2(V)V. This minimization problem is solved by a
modified Newton method with an active set strategy [28].
To quantify radiopharmaceutical uptake in vivo in a small
animal by means of hybrid spectral CLT/CT, a CCD camera was
calibrated using an integrating sphere of 12 inches in diameter
(USS-1200V-LL Low-Light Uniform Source, Labsphere, North
Sutton, NH). The calibrated method was introduced in the
literature [29]. The calibration formula is given as follows:
E~10{4|
8(az20)z72t
t
|(10:48{
10:48m
n
) ð11Þ
where E (nW/mm
2) is the irradiance intensity on the mouse
surface; a is the pixel gray value of the Cerenkov luminescent
image; t (s) is the exposure time for the Cerenkov luminescent
image acquisition; m (mm) is the distance between the center of the
lens front face and the intersection of the principal optical axis and
the mouse frontal surface; and n (mm) is the distance between the
edge of the cylindrical lens and the intersection of the principal
optical axis and the mouse frontal surface.
Supporting Information
Figure S1 The correlation between the reconstructed
source energy and activity. Athymic nude mice (n~6, weight
1662 g) underwent aseptic celiotomy and were implanted with
100 mCi, 200 mCi, 300 mCi, 400 mCi, 500 mCi and 600 mCi
Na
131I radioactive sources into the mouse bellies respectively.
The depth of the embedded radioactive source was approximately
4 mm from the top surface of the mouse. We then acquired a
single luminescent image with the IVIS system without utilizing
filters and then we collected CT images using the SPECT-CT
system (Symbia T2, Siemens). We reconstructed the location and
energy of the Na
131I radioactive sources based on hybrid spectral
CLT. Our results showed that there was a very good linear
correlation between the reconstructed source energy and the
activity of the Cerenkov luminescent source
(y~{0:00648z4:56574E{5   xr 2~0:9365).
(TIF)
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